JP2006507277A - 24時間有効な持続放出トラマドール製剤 - Google Patents
24時間有効な持続放出トラマドール製剤 Download PDFInfo
- Publication number
- JP2006507277A JP2006507277A JP2004545655A JP2004545655A JP2006507277A JP 2006507277 A JP2006507277 A JP 2006507277A JP 2004545655 A JP2004545655 A JP 2004545655A JP 2004545655 A JP2004545655 A JP 2004545655A JP 2006507277 A JP2006507277 A JP 2006507277A
- Authority
- JP
- Japan
- Prior art keywords
- hours
- composition
- tramadol
- administration
- plasma concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28102602A | 2002-10-25 | 2002-10-25 | |
US51037803P | 2003-10-10 | 2003-10-10 | |
PCT/CA2003/001638 WO2004037222A2 (fr) | 2002-10-25 | 2003-10-27 | Preparations de tramadol a liberation soutenue dotees d'une efficacite de 24 heures |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2006507277A true JP2006507277A (ja) | 2006-03-02 |
Family
ID=32179487
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004545655A Pending JP2006507277A (ja) | 2002-10-25 | 2003-10-27 | 24時間有効な持続放出トラマドール製剤 |
Country Status (11)
Country | Link |
---|---|
JP (1) | JP2006507277A (fr) |
KR (1) | KR20050083816A (fr) |
AR (1) | AR045972A1 (fr) |
AU (1) | AU2003275855B2 (fr) |
CA (1) | CA2503155A1 (fr) |
IL (1) | IL168114A (fr) |
NO (1) | NO20052479D0 (fr) |
PT (1) | PT1594460E (fr) |
RU (1) | RU2328275C2 (fr) |
UA (1) | UA84277C2 (fr) |
WO (1) | WO2004037222A2 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009534429A (ja) * | 2006-04-26 | 2009-09-24 | アルファファーム ピーティーワイ リミテッド | コーティングされていない分離したユニットおよび延長放出マトリクスを含む制御放出配合物 |
JP2019519488A (ja) * | 2016-05-05 | 2019-07-11 | アクエスティブ セラピューティクス インコーポレイテッド | 透過性増強された医薬組成物 |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
TWI319713B (en) | 2002-10-25 | 2010-01-21 | Sustained-release tramadol formulations with 24-hour efficacy | |
US8487002B2 (en) | 2002-10-25 | 2013-07-16 | Paladin Labs Inc. | Controlled-release compositions |
EP1905435A3 (fr) * | 2003-03-11 | 2008-05-14 | Euro-Celtique S.A. | Régime de dosage de titrage pour tramadol à libération contrôlée |
US7413749B2 (en) | 2003-03-11 | 2008-08-19 | Purdue Pharma L.P. | Titration dosing regimen for controlled release tramadol |
DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
BRPI0511137A (pt) * | 2004-05-14 | 2007-11-27 | Janssen Pharmaceutica Nv | compostos opióides de carboxamido |
DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
PL1931346T3 (pl) * | 2005-09-09 | 2013-01-31 | Angelini Labopharm Llc | Kompozycja trazodonu do podawania raz na dobę |
JP5774853B2 (ja) | 2008-01-25 | 2015-09-09 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 医薬投薬形 |
TWI524904B (zh) | 2008-05-09 | 2016-03-11 | 歌林達股份有限公司 | 製備醫藥用固體劑型,尤指錠劑之方法,及製備固體劑型,尤指錠劑之前驅物之方法 |
AU2009253739B2 (en) | 2008-05-27 | 2014-02-06 | Otolanum Ag | Methods of treating mammals with eustachian tube dysfunctions |
CA2741751C (fr) * | 2008-10-27 | 2017-05-09 | Alza Corporation | Forme posologique orale d'acetaminophene/tramadol a liberation prolongee |
CA2765971C (fr) | 2009-07-22 | 2017-08-22 | Gruenenthal Gmbh | Forme galenique extrudee a chaud a liberation controlee |
JP2012533586A (ja) | 2009-07-22 | 2012-12-27 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 酸化安定化された不正使用防止剤形 |
ES2606227T3 (es) | 2010-02-03 | 2017-03-23 | Grünenthal GmbH | Preparación de una composición farmacéutica en polvo mediante una extrusora |
NZ608865A (en) | 2010-09-02 | 2015-03-27 | Gruenenthal Chemie | Tamper resistant dosage form comprising an anionic polymer |
AU2011297901B2 (en) | 2010-09-02 | 2014-07-31 | Grunenthal Gmbh | Tamper resistant dosage form comprising inorganic salt |
CN103841964A (zh) | 2011-07-29 | 2014-06-04 | 格吕伦塔尔有限公司 | 提供药物立即释放的抗破碎片剂 |
PT2736497T (pt) | 2011-07-29 | 2017-11-30 | Gruenenthal Gmbh | Comprimido resistente a adulteração proporcionando libertação imediata de fármaco |
JP6117249B2 (ja) | 2012-02-28 | 2017-04-19 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 薬理学的に活性な化合物および陰イオン性ポリマーを含むタンパーレジスタント剤形 |
WO2013156453A1 (fr) | 2012-04-18 | 2013-10-24 | Grünenthal GmbH | Forme pharmaceutique inviolable et résistante à la libération massive |
US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
MX371432B (es) | 2013-05-29 | 2020-01-30 | Gruenenthal Gmbh | Forma de dosificacion resistente al uso indebido que contiene una o mas particulas. |
CA2913209A1 (fr) | 2013-05-29 | 2014-12-04 | Grunenthal Gmbh | Forme dosifiee inviolable a profil de liberation bimodale |
MX368846B (es) | 2013-07-12 | 2019-10-18 | Gruenenthal Gmbh | Forma de dosificación resistente a la alteración que contiene polímero de acetato de etilen-vinilo. |
EP3073994A1 (fr) | 2013-11-26 | 2016-10-05 | Grünenthal GmbH | Préparation de composition pharmaceutique en poudre par cryo-broyage |
EP3142646A1 (fr) | 2014-05-12 | 2017-03-22 | Grünenthal GmbH | Formulation pour capsule à libération immédiate résistant aux manipulations illicites comprenant du tapentadol |
EA201692388A1 (ru) | 2014-05-26 | 2017-05-31 | Грюненталь Гмбх | Лекарственная форма в виде множества частиц, защищенная от вызываемого этанолом сброса дозы |
EA035434B1 (ru) | 2015-04-24 | 2020-06-15 | Грюненталь Гмбх | Защищенная от применения не по назначению лекарственная форма с немедленным высвобождением и устойчивостью к экстракции растворителями |
EP3346991A1 (fr) | 2015-09-10 | 2018-07-18 | Grünenthal GmbH | Protection contre un surdosage par voie orale à l'aide de formulations à libération immédiate dissuasives d'abus |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0753361A (ja) * | 1993-05-10 | 1995-02-28 | Euro Celtique Sa | 放出が調整された調合物、経口投与形態及びその製造方法 |
JP2000510487A (ja) * | 1997-07-02 | 2000-08-15 | ユーロ―セルティーク,エス.エイ. | 安定化された徐放性トラマドール製剤 |
JP2001278813A (ja) * | 2000-03-29 | 2001-10-10 | Basf Ag | 遅延された作用物質の放出および高い機械的安定性を有する経口投与形、前記投与形の医薬品および該投与形の使用 |
WO2002002084A1 (fr) * | 2000-06-29 | 2002-01-10 | Vincent Lenaerts | Amidon reticule a forte teneur en amylose pouvant etre utilise dans des preparations pharmaceutique a liberation prolongee et procedes de fabrication associes |
WO2002066026A2 (fr) * | 2001-02-21 | 2002-08-29 | Grünenthal GmbH | Medicament a base de tramadol |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19530575A1 (de) * | 1995-08-19 | 1997-02-20 | Gruenenthal Gmbh | Schnell zerfallende Arzneiform von Tramadol oder einem Tramadolsalz |
-
2003
- 2003-10-27 CA CA002503155A patent/CA2503155A1/fr not_active Abandoned
- 2003-10-27 AR ARP030103926A patent/AR045972A1/es unknown
- 2003-10-27 KR KR1020057007089A patent/KR20050083816A/ko not_active Application Discontinuation
- 2003-10-27 UA UAA200504852A patent/UA84277C2/ru unknown
- 2003-10-27 WO PCT/CA2003/001638 patent/WO2004037222A2/fr active IP Right Grant
- 2003-10-27 RU RU2005115855/15A patent/RU2328275C2/ru not_active IP Right Cessation
- 2003-10-27 PT PT03809237T patent/PT1594460E/pt unknown
- 2003-10-27 AU AU2003275855A patent/AU2003275855B2/en not_active Expired
- 2003-10-27 JP JP2004545655A patent/JP2006507277A/ja active Pending
-
2005
- 2005-04-19 IL IL168114A patent/IL168114A/en active IP Right Grant
- 2005-05-23 NO NO20052479A patent/NO20052479D0/no not_active Application Discontinuation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0753361A (ja) * | 1993-05-10 | 1995-02-28 | Euro Celtique Sa | 放出が調整された調合物、経口投与形態及びその製造方法 |
JP2000510487A (ja) * | 1997-07-02 | 2000-08-15 | ユーロ―セルティーク,エス.エイ. | 安定化された徐放性トラマドール製剤 |
JP2001278813A (ja) * | 2000-03-29 | 2001-10-10 | Basf Ag | 遅延された作用物質の放出および高い機械的安定性を有する経口投与形、前記投与形の医薬品および該投与形の使用 |
WO2002002084A1 (fr) * | 2000-06-29 | 2002-01-10 | Vincent Lenaerts | Amidon reticule a forte teneur en amylose pouvant etre utilise dans des preparations pharmaceutique a liberation prolongee et procedes de fabrication associes |
WO2002066026A2 (fr) * | 2001-02-21 | 2002-08-29 | Grünenthal GmbH | Medicament a base de tramadol |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009534429A (ja) * | 2006-04-26 | 2009-09-24 | アルファファーム ピーティーワイ リミテッド | コーティングされていない分離したユニットおよび延長放出マトリクスを含む制御放出配合物 |
JP2019519488A (ja) * | 2016-05-05 | 2019-07-11 | アクエスティブ セラピューティクス インコーポレイテッド | 透過性増強された医薬組成物 |
Also Published As
Publication number | Publication date |
---|---|
AU2003275855B2 (en) | 2009-04-23 |
RU2328275C2 (ru) | 2008-07-10 |
AR045972A1 (es) | 2005-11-23 |
UA84277C2 (ru) | 2008-10-10 |
IL168114A (en) | 2011-05-31 |
WO2004037222A2 (fr) | 2004-05-06 |
NO20052479L (no) | 2005-05-23 |
KR20050083816A (ko) | 2005-08-26 |
PT1594460E (pt) | 2008-06-27 |
CA2503155A1 (fr) | 2004-05-06 |
WO2004037222A3 (fr) | 2005-09-22 |
RU2005115855A (ru) | 2006-01-20 |
AU2003275855A1 (en) | 2004-05-13 |
NO20052479D0 (no) | 2005-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2006507277A (ja) | 24時間有効な持続放出トラマドール製剤 | |
US8487002B2 (en) | Controlled-release compositions | |
CA2489855C (fr) | Formulations de tramadol a liberation prolongee ayant une efficacite clinique de 24 heures | |
US7988998B2 (en) | Sustained-release tramadol formulations with 24-hour efficacy | |
ES2273790T3 (es) | Composicion farmaceutica de liberacion sostenida. | |
KR101317592B1 (ko) | 프레가발린, 폴리에틸렌옥사이드 및 폴리비닐알코올-폴리에틸렌글리콜 그라프트 공중합체를 함유하는 위체류형 서방성 제제 | |
AU2010289022B2 (en) | New compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine | |
JP2006507276A (ja) | 放出制御組成物 | |
PT1476138E (pt) | Formulações de libertação modificada de pelo menos uma forma de tramadol | |
US20230240999A1 (en) | Novel fine particle coating (drug-containing hollow particle and method for manufacturing same) | |
TW201206501A (en) | Pharmaceutical compositions comprising hydromorphone and naloxone | |
AU2003237807B2 (en) | Sustained release of guaifenesin combination drugs | |
JP4897930B2 (ja) | 放出制御組成物 | |
JP2004217566A (ja) | 製剤のゲル強度の増強方法および徐放性製剤 | |
US20210346303A1 (en) | Coating method | |
ZA200504216B (en) | Sustained-release tramadol formulations with 24-hour efficacy | |
BRPI0315657B1 (pt) | formulação de dosagem sólida, e comprimido |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20061020 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100727 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101026 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101027 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110517 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110810 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110817 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110914 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110922 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20111007 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20111017 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120228 |